Phibro Animal Health (PAHC) Cost of Revenue (2012 - 2026)
Phibro Animal Health (PAHC) posted quarterly Cost of Revenue of $257.9 million for Q1 2026, up 6.01% year-over-year from $243.3 million in Q1 2025, and up 6.89% quarter-over-quarter from $241.3 million in Q4 2025.
Phibro Animal Health (PAHC) Cost of Revenue (2012 - 2026) Analysis & Trends
Phibro Animal Health's Cost of Revenue history runs 15 years deep, the most recent figure standing at $257.9 million for Q1 2026.
- In Q1 2026, Cost of Revenue rose 6.01% year-over-year to $257.9 million; the TTM figure through Mar 2026 stood at $1.0 billion (up 24.38% YoY), while the FY2025 annual figure was $896.3 million, up 27.21% from the prior year.
- Cost of Revenue for Q1 2026 stood at $257.9 million, up from $241.3 million in the prior quarter.
- The five-year high for Cost of Revenue was $268.7 million in Q2 2025, with the low at $163.6 million in Q3 2023.
- The 5-year median for Cost of Revenue is $178.4 million (2023), against an average of $198.2 million.
- The sharpest annual moves came in 2023 and 2025: Cost of Revenue declined 0.15% in 2023, then soared 44.45% in 2025.
- Phibro Animal Health's Cost of Revenue stood at $167.3 million in 2022, then advanced by 2.43% to $171.3 million in 2023, then gained by 21.05% to $207.4 million in 2024, then increased by 16.33% to $241.3 million in 2025, then grew by 6.89% to $257.9 million in 2026.
- Business Quant data shows PAHC's Cost of Revenue at $257.9 million in Q1 2026, $241.3 million in Q4 2025, and $244.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | 1.99 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 2.55 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 99.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | 2.30 Bn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 23.20 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 570.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Phibro Animal Health | 1.43 Bn | 1.36 Bn | 125.68 Mn | 257.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 257.87 Mn |
| Mar 31, 2026 | 257.87 Mn |
| Dec 31, 2025 | 241.25 Mn |
| Dec 31, 2025 | 241.25 Mn |
| Sep 30, 2025 | 244.11 Mn |
| Sep 30, 2025 | 244.11 Mn |
| Jun 30, 2025 | 268.69 Mn |
| Jun 30, 2025 | 268.69 Mn |
| Mar 31, 2025 | 243.26 Mn |
| Mar 31, 2025 | 243.26 Mn |
| Dec 31, 2024 | 207.39 Mn |
| Dec 31, 2024 | 207.39 Mn |
| Sep 30, 2024 | 176.94 Mn |
| Sep 30, 2024 | 176.94 Mn |
| Jun 30, 2024 | 186.01 Mn |
| Jun 30, 2024 | 186.01 Mn |
| Mar 31, 2024 | 183.62 Mn |
| Mar 31, 2024 | 183.62 Mn |
| Dec 31, 2023 | 171.33 Mn |
| Dec 31, 2023 | 171.33 Mn |